C1-inhibitor treatment in patients with severe complement-mediated autoimmune hemolytic anemia.

Autor: de Boer ECW; Department of Immunopathology, Sanquin Research and Landsteiner Laboratory, Amsterdam University Medical Centre, Amsterdam Infection and Immunity Institute, Amsterdam, The Netherlands.; Department of Pediatric Immunology, Rheumatology, and Infectious Diseases, Emma Children's Hospital, Amsterdam University Medical Center, Amsterdam, The Netherlands., Jalink M; Department of Clinical Transfusion Research, Sanquin Research, Amsterdam, The Netherlands.; Department of Hematology, Amsterdam University Medical Center, Amsterdam, The Netherlands.; Department of Transfusion Medicine, Sanquin Blood Supply, Amsterdam, The Netherlands., Delvasto-Nuñez L; Department of Immunopathology, Sanquin Research and Landsteiner Laboratory, Amsterdam University Medical Centre, Amsterdam Infection and Immunity Institute, Amsterdam, The Netherlands., Meulenbroek EM; Department of Immunopathology, Sanquin Research and Landsteiner Laboratory, Amsterdam University Medical Centre, Amsterdam Infection and Immunity Institute, Amsterdam, The Netherlands., Baas I; Department of Immunopathology, Sanquin Research and Landsteiner Laboratory, Amsterdam University Medical Centre, Amsterdam Infection and Immunity Institute, Amsterdam, The Netherlands., Janssen SR; Department of Hematology, Amsterdam University Medical Center, Amsterdam, The Netherlands., Folman CC; Department of Immunohematology Diagnostics, Sanquin, Amsterdam, The Netherlands., Gelderman KA; Sanquin Diagnostic Services, Amsterdam, The Netherlands., Wouters D; Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, The Netherlands., Engel MD; Department of Hematology, Amsterdam University Medical Center, Amsterdam, The Netherlands., de Haas M; Department of Clinical Transfusion Research, Sanquin Research, Amsterdam, The Netherlands.; Department of Immunohematology Diagnostics, Sanquin, Amsterdam, The Netherlands.; Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands., Kersten MJ; Department of Hematology, Amsterdam University Medical Centers, Location University of Amsterdam, Cancer Center Amsterdam and Lymphoma and Myeloma Center Amsterdam, Amsterdam, The Netherlands., Jongerius I; Department of Immunopathology, Sanquin Research and Landsteiner Laboratory, Amsterdam University Medical Centre, Amsterdam Infection and Immunity Institute, Amsterdam, The Netherlands.; Department of Pediatric Immunology, Rheumatology, and Infectious Diseases, Emma Children's Hospital, Amsterdam University Medical Center, Amsterdam, The Netherlands., Zeerleder S; Department of Hematology, Luzerner Kantonsspital, Luzern, Switzerland.; Department for BioMedical Research, University of Bern, Bern, Switzerland., Vos JMI; Department of Immunohematology Diagnostics, Sanquin, Amsterdam, The Netherlands.; Department of Hematology, Amsterdam University Medical Centers, Location University of Amsterdam, Cancer Center Amsterdam and Lymphoma and Myeloma Center Amsterdam, Amsterdam, The Netherlands.

Publikováno v: Blood advances [Blood Adv] 2023 Jul 11; Vol. 7 (13), pp. 3128-3139.

Reduction of anti-K-mediated hemolytic disease of newborns after the introduction of a matched transfusion policy: A nation-wide policy change evaluation study in the Netherlands.

Autor: Luken JS; Department of Immunohematology Diagnostics, Sanquin Diagnostic Services, Amsterdam, The Netherlands., Folman CC; Department of Immunohematology Diagnostics, Sanquin Diagnostic Services, Amsterdam, The Netherlands., Lukens MV; Department of Laboratory Medicine, University Medical Center Groningen (UMCG), Groningen, The Netherlands., Meekers JH; Department of Laboratory Medicine, University Medical Center Groningen (UMCG), Groningen, The Netherlands., Ligthart PC; Department of Immunohematology Diagnostics, Sanquin Diagnostic Services, Amsterdam, The Netherlands., Schonewille H; Department of Experimental Immunohematology, Sanquin Research, Amsterdam, The Netherlands.; Landsteiner Laboratory, University of Amsterdam, Amsterdam, The Netherlands., Zwaginga JJ; Department of Immunohematology and Blood Transfusion, Leiden University Medical Center, Leiden, The Netherlands.; Center for Clinical Transfusion Research, Sanquin Research, Leiden, The Netherlands., Janssen MP; Transfusion Technology Assessment Department, Donor Medicine Research, Sanquin Research, Amsterdam, The Netherlands., van der Schoot CE; Department of Experimental Immunohematology, Sanquin Research, Amsterdam, The Netherlands.; Landsteiner Laboratory, University of Amsterdam, Amsterdam, The Netherlands., van der Bom JG; Center for Clinical Transfusion Research, Sanquin Research, Leiden, The Netherlands.; Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands., de Haas M; Department of Immunohematology Diagnostics, Sanquin Diagnostic Services, Amsterdam, The Netherlands.; Department of Immunohematology and Blood Transfusion, Leiden University Medical Center, Leiden, The Netherlands.; Center for Clinical Transfusion Research, Sanquin Research, Leiden, The Netherlands.

Publikováno v: Transfusion [Transfusion] 2021 Mar; Vol. 61 (3), pp. 713-721. Date of Electronic Publication: 2021 Feb 02.

Non-linear association of the platelet/high-density lipoprotein cholesterol ratio with bone mineral density a cross-sectional study.

Autor: Ye, Haobo¹ (AUTHOR), Chen, Zihao¹ (AUTHOR), Li, Kaiyu¹ (AUTHOR), Zhang, Yekai¹ (AUTHOR), Li, Hualin¹ (AUTHOR), Tian, Naifeng¹ (AUTHOR) naifengtian@wmu.edu.cn

Publikováno v: Lipids in Health & Disease. 9/16/2024, Vol. 23 Issue 1, p1-10. 10p.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.